跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96,145 条关于
“APOL1 kidney disease”
全部
96,145
临床试验
72,925
药物
1,503
机构
209
资讯
21,508
去年
Maze Therapeutics' MZE829 Shows Promise in Phase 1 Trial for APOL1 Kidney Disease
去年
Maze Therapeutics' MZE829 Shows Promise in Phase I Trial for APOL1 Kidney Disease
去年
Maze Therapeutics Initiates Phase 2 Trial of MZE829 for APOL1 Kidney Disease
去年
Maze Therapeutics Secures $115 Million to Advance Kidney Disease Therapies
2年前
Inaxaplin Shows Promise in Addressing APOL1-Mediated Kidney Disease Disparity in Black Americans
去年
Atlas Venture Closes $450M Fund XIV, Nuvig, Maze, and Antag Secure Financing for Biotech Innovation
5个月前
Proteomic Blood Test Predicts Kidney Failure in APOL1 High-Risk Individuals Years Before Symptoms Emerge
去年
Vertex Announces Positive Updates on Kidney Disease Programs at ASN Kidney Week
去年
Vertex Pharmaceuticals Awaits FDA Decision on Suzetrigine for Acute Pain
上个月
Maze Therapeutics Appoints Paula Johnson and Sophie Kornowski to Board of Directors
第 1 页,共 2151 页
上一页
下一页